#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Important current information of consensus statement of EAS on low-density lipoproteins: editorial

Czech version

Authors: Rudolf Poledne
Published in: AtheroRev 2021; 6(1): 6
Category:

Sources

Borén J, Chapman MJ, Krauss RM et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2020; 41(24): 2313–2330. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehz962>.
Kraml P, Vrablík M, Blaha V et al. Druhý konsenzus EAS o lipoproteinech o nízké hustotě: stanovisko výboru České společnosti pro aterosklerózu. AtheroRev 2021; 6(1): 9–16.

Labels

Angiology Diabetology Internal medicine Cardiology General practitioner for adults

Second consensus statement of European Atherosclerosis Society on low-density lipoproteins: statement of Czech Society for Atherosclerosis

Liečba dyslipidémií počas pandémie COVID-19

Antiatherosclerotic and antiinflammatory activities of SGLT2 inhibitors

Early cardiovascular risk intervention means cummulation of positive impacts in time

Why we need to improve serum levels of cholesterol after percutanneous coronary intervention

Low concentration of plasma cholesterol and type 2. diabetes mellitus

Comment on Low concentration of plasma cholesterol and type 2. diabetes mellitus

How we are (un)successful in the managing of dyslipidemia and why

Inclisiran: the first siRNA approved by European Medicines Agency for treatment of dyslipidemias

Rešerše zajímavých článků ze zahraniční literatury

24. virtuální kongres o ateroskleróze

Article was published in

Athero Review

Issue 1

2021 Issue 1

Most read in this issue

#ADS_BOTTOM_SCRIPTS#